Skip to main navigation Skip to search Skip to main content

Mice with a Brd4 Mutation Represent a New Model of Nephrocalcinosis

  • Caroline M. Gorvin
  • , Nellie Y. Loh
  • , Michael J. Stechman
  • , Sara Falcone
  • , Fadil M. Hannan
  • , Bushra N. Ahmad
  • , Sian E. Piret
  • , Anita A.C. Reed
  • , Jeshmi Jeyabalan
  • , Paul Leo
  • , Mhairi Marshall
  • , Siddharth Sethi
  • , Paul Bass
  • , Ian Roberts
  • , Jeremy Sanderson
  • , Sara Wells
  • , Tertius A. Hough
  • , Liz Bentley
  • , Paul T. Christie
  • , Michelle M. Simon
  • Ann Marie Mallon, Herbert Schulz, Roger D. Cox, Matthew A. Brown, Norbert Huebner, Steve D. Brown, Rajesh V. Thakker
  • University of Oxford
  • University of Liverpool
  • Queensland University of Technology
  • Medical Research Council
  • Royal Free London NHS Foundation Trust
  • John Radcliffe Hospital
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Nephrolithiasis (NL) and nephrocalcinosis (NC), which comprise renal calcification of the collecting system and parenchyma, respectively, have a multifactorial etiology with environmental and genetic determinants and affect ∼10% of adults by age 70 years. Studies of families with hereditary NL and NC have identified >30 causative genes that have increased our understanding of extracellular calcium homeostasis and renal tubular transport of calcium. However, these account for <20% of the likely genes that are involved, and to identify novel genes for renal calcification disorders, we investigated 1745 12-month-old progeny from a male mouse that had been treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) for radiological renal opacities. This identified a male mouse with renal calcification that was inherited as an autosomal dominant trait with >80% penetrance in 152 progeny. The calcification consisted of calcium phosphate deposits in the renal papillae and was associated with the presence of the urinary macromolecules osteopontin and Tamm-Horsfall protein, which are features found in Randall's plaques of patients with NC. Genome-wide mapping located the disease locus to a ∼30 Mbp region on chromosome 17A3.3-B3 and whole-exome sequence analysis identified a heterozygous mutation, resulting in a missense substitution (Met149Thr, M149T), in the bromodomain-containing protein 4 (BRD4). The mutant heterozygous (Brd4+/M149T) mice, when compared with wild-type (Brd4+/+) mice, were normocalcemic and normophosphatemic, with normal urinary excretions of calcium and phosphate, and had normal bone turnover markers. BRD4 plays a critical role in histone modification and gene transcription, and cDNA expression profiling, using kidneys from Brd4+/M149T and Brd4+/+ mice, revealed differential expression of genes involved in vitamin D metabolism, cell differentiation, and apoptosis. Kidneys from Brd4+/M149T mice also had increased apoptosis at sites of calcification within the renal papillae. Thus, our studies have established a mouse model, due to a Brd4 Met149Thr mutation, for inherited NC.

Original languageEnglish
Pages (from-to)1324-1335
Number of pages12
JournalJournal of Bone and Mineral Research
Volume34
Issue number7
DOIs
StatePublished - Jul 2019

Keywords

  • BRD4 MUTATION
  • MOUSE MODEL
  • NEPHROCALCINOSIS
  • NEPHROLITHIASIS

Fingerprint

Dive into the research topics of 'Mice with a Brd4 Mutation Represent a New Model of Nephrocalcinosis'. Together they form a unique fingerprint.

Cite this